Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prevalence of Psoriasis Alba in Psoriatic Patients

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00835315
First received: February 1, 2009
Last updated: August 11, 2010
Last verified: February 2009
  Purpose

Interdigital psoriasis (psoriasis alba) is atypical and rare form of psoriasis that is often missed as it is commonly mistaken for either dermatoses or fungal infection.In this study we observed and analyzed the prevalence of psoriasis interdigital of palms and soles and brought medical awareness to dermatologists and family doctors this rare form of psoriasis. Thus, you can help to avoid mistaken diagnosis and the start of correct treatment as soon as possible.


Condition
Psoriasis

Study Type: Observational
Study Design: Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Enrollment: 300
Study Start Date: January 2008
Groups/Cohorts
3
patients with psoriasis , patients with atopic dermatitis and healthy patients.

Detailed Description:

Hospitalized patients and outpatient clinic will be included in the study after receiving the signature of a inform consent.Patients groups : 100 patients with psoriasis,100 patients with atopic dermatitis and 100 healthy patients (control group).Patients with atopic dermatitis will be the secondary control group.Patients diagnosed with inflammatory condition of interdigital skin of the palms and soles will be checked by fungal microscopy test.If the fungal test is negative ,we need to prepare to a biopsy of the skin in this area .Following results of the skin biopsy conclusions can be shown about the prevalence of interdigital psoriasis in psoriatic patients enabling suitable treatment to be given to the patients.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

patients of dermatology depatment and outpatient clinic in the hospital

Criteria

Inclusion Criteria:

  • patients above 18 years old ,hebrew speakers, patients with psoriasis vulgaris or atopic dermatitis without systemic treatment

Exclusion Criteria:

  • patients below 18 years old, pregnancy women, patients treated with systemic agents for psoriasis or atopic dermatitis(methotrexate,cyclosporin,neotigason)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00835315

Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Vera Leibovici, MD Hadassah Medical Organization
Principal Investigator: Natalya Lemster, MD Hadassah Medical Organization
  More Information

No publications provided

Responsible Party: hadassa medical organization,jerusalem,israel, hadassah medical organization
ClinicalTrials.gov Identifier: NCT00835315     History of Changes
Other Study ID Numbers: IPS001-HMO-CTIL
Study First Received: February 1, 2009
Last Updated: August 11, 2010
Health Authority: Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:
interdigital psoriasis (psoriasis alba)

Additional relevant MeSH terms:
Psoriasis
Skin Diseases
Skin Diseases, Papulosquamous

ClinicalTrials.gov processed this record on November 20, 2014